-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Ligand Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q4 2024.
- Ligand Pharmaceuticals Inc Operating Income (Loss) for the quarter ending December 31, 2024 was -$9.64M, a 187% decline year-over-year.
- Ligand Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending December 31, 2024 was -$22.6M, a 289% decline year-over-year.
- Ligand Pharmaceuticals Inc annual Operating Income (Loss) for 2024 was -$22.6M, a 289% decline from 2023.
- Ligand Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was $11.9M, a 293% increase from 2022.
- Ligand Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was $3.04M, a 97.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)